Healthpeak Properties (DOC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
3 Mar, 2026Strategic initiatives and recent updates
Announced the formation and planned IPO of Janus Living to unlock value and leverage expertise, with confidential and public S-11 filings completed by February 2026.
Focused on capital recycling, targeting $1B in asset sales, recapitalizations, and loan repayments, including $212M under LOI.
Technology initiatives led by a new Head of Enterprise Innovation, emphasizing automation and improved tenant experience.
Lab fundamentals are improving, with the Bay Area leading in leasing and active tenant demand.
Capital allocation and acquisitions
Acquired a 1.4M SF campus in South San Francisco for $600M, expanding the Gateway footprint to 43 contiguous acres and solidifying leadership in the biotech submarket.
Sourced $675M in senior housing investment opportunities in 4Q25, with targeted stabilized cash NOI yields of 8.0% to 9.0%.
Closed $511M in asset sales and loan repayments in 2025, with 2026 guidance including $1B in proceeds from dispositions, recaps, and loan repayments.
Platform overview and portfolio scale
Owns and operates 689 properties with $25B in total portfolio investment, 50M SF, and 10,422 senior housing units.
Outpatient medical portfolio: 37M SF, $807M adjusted NOI, 91% occupancy, 70% leased to health systems.
Lab portfolio: 13M SF, $567M adjusted NOI, concentrated in Bay Area, Boston, and San Diego.
Senior housing: 10,422 units, $197M adjusted NOI, high concentration in Florida and Texas.
Latest events from Healthpeak Properties
- Key votes include board elections, executive pay approval, and auditor ratification for 2026.DOC
Proxy Filing12 Mar 2026 - 2025 saw strong results, board refreshment, and enhanced ESG, with key votes on directors, pay, and auditor.DOC
Proxy Filing12 Mar 2026 - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - 2026 guidance anticipates a bottom in FFO, with growth expected as lab and senior housing recover.DOC
Q4 20253 Feb 2026 - Q2 net income surged, guidance raised, and $1.2B in asset sales completed.DOC
Q2 20242 Feb 2026 - Merger-driven scale, strong leasing, and robust financials support optimistic growth outlook.DOC
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong leasing, NOI growth, and higher guidance, fueled by merger synergies.DOC
Q3 202418 Jan 2026 - 2024 delivered strong growth and synergies, with 2025 set for continued investment and expansion.DOC
Q4 20248 Jan 2026 - Outpatient and life science platforms drive growth, with lab supply peaking and CCRC margins rising.DOC
Citi’s 30th Annual Global Property CEO Conference 20257 Jan 2026